188 related articles for article (PubMed ID: 9881766)
1. Enzymatic basis for sialyl-Tn expression in human colon cancer cells.
Brockhausen I; Yang J; Dickinson N; Ogata S; Itzkowitz SH
Glycoconj J; 1998 Jun; 15(6):595-603. PubMed ID: 9881766
[TBL] [Abstract][Full Text] [Related]
2. Pathways of mucin O-glycosylation in normal and malignant rat colonic epithelial cells reveal a mechanism for cancer-associated Sialyl-Tn antigen expression.
Brockhausen I; Yang J; Lehotay M; Ogata S; Itzkowitz S
Biol Chem; 2001 Feb; 382(2):219-32. PubMed ID: 11308020
[TBL] [Abstract][Full Text] [Related]
3. Alterations of O-glycan biosynthesis in human colon cancer tissues.
Yang JM; Byrd JC; Siddiki BB; Chung YS; Okuno M; Sowa M; Kim YS; Matta KL; Brockhausen I
Glycobiology; 1994 Dec; 4(6):873-84. PubMed ID: 7734850
[TBL] [Abstract][Full Text] [Related]
4. O-glycan biosynthesis in human colorectal adenoma cells during progression to cancer.
Vavasseur F; Dole K; Yang J; Matta KL; Myerscough N; Corfield A; Paraskeva C; Brockhausen I
Eur J Biochem; 1994 Jun; 222(2):415-24. PubMed ID: 8020479
[TBL] [Abstract][Full Text] [Related]
5. The pattern of glycosyl- and sulfotransferase activities in cancer cell lines: a predictor of individual cancer-associated distinct carbohydrate structures for the structural identification of signature glycans.
Chandrasekaran EV; Xue J; Neelamegham S; Matta KL
Carbohydr Res; 2006 Jun; 341(8):983-94. PubMed ID: 16545347
[TBL] [Abstract][Full Text] [Related]
6. Suppression of core 1 Gal-transferase is associated with reduction of TF and reciprocal increase of Tn, sialyl-Tn and Core 3 glycans in human colon cancer cells.
Barrow H; Tam B; Duckworth CA; Rhodes JM; Yu LG
PLoS One; 2013; 8(3):e59792. PubMed ID: 23536887
[TBL] [Abstract][Full Text] [Related]
7. Two different glycosyltransferase defects that result in GalNAc alpha-O-peptide (Tn) expression.
King MJ; Chan A; Roe R; Warren BF; Dell A; Morris HR; Bartolo DC; Durdey P; Corfield AP
Glycobiology; 1994 Jun; 4(3):267-79. PubMed ID: 7949653
[TBL] [Abstract][Full Text] [Related]
8. Effect of benzyl-alpha-GalNAc, an inhibitor of mucin glycosylation, on cancer-associated antigens in human colon cancer cells.
Huang J; Byrd JC; Yoon WH; Kim YS
Oncol Res; 1992; 4(11-12):507-15. PubMed ID: 1284381
[TBL] [Abstract][Full Text] [Related]
9. Biosynthesis of O-glycans in leukocytes from normal donors and from patients with leukemia: increase in O-glycan core 2 UDP-GlcNAc:Gal beta 3 GalNAc alpha-R (GlcNAc to GalNAc) beta(1-6)-N-acetylglucosaminyltransferase in leukemic cells.
Brockhausen I; Kuhns W; Schachter H; Matta KL; Sutherland DR; Baker MA
Cancer Res; 1991 Feb; 51(4):1257-63. PubMed ID: 1997166
[TBL] [Abstract][Full Text] [Related]
10. Glycosyltransferase changes upon differentiation of CaCo-2 human colonic adenocarcinoma cells.
Brockhausen I; Romero PA; Herscovics A
Cancer Res; 1991 Jun; 51(12):3136-42. PubMed ID: 1904002
[TBL] [Abstract][Full Text] [Related]
11. Mucin oligosaccharide biosynthesis in human colonic cancerous tissues and cell lines.
Dahiya R; Itzkowitz SH; Byrd JC; Kim YS
Cancer; 1992 Sep; 70(6):1467-76. PubMed ID: 1515998
[TBL] [Abstract][Full Text] [Related]
12. T cell clones with normal or defective O-galactosylation from a patient with permanent mixed-field polyagglutinability.
Thurnher M; Clausen H; Fierz W; Lanzavecchia A; Berger EG
Eur J Immunol; 1992 Jul; 22(7):1835-42. PubMed ID: 1378020
[TBL] [Abstract][Full Text] [Related]
13. Expression of sialyl-Tn antigen in breast cancer cells transfected with the human CMP-Neu5Ac: GalNAc alpha2,6-sialyltransferase (ST6GalNac I) cDNA.
Julien S; Krzewinski-Recchi MA; Harduin-Lepers A; Gouyer V; Huet G; Le Bourhis X; Delannoy P
Glycoconj J; 2001; 18(11-12):883-93. PubMed ID: 12820722
[TBL] [Abstract][Full Text] [Related]
14. Polypeptide GalNAc-transferases, ST6GalNAc-transferase I, and ST3Gal-transferase I expression in gastric carcinoma cell lines.
Marcos NT; Cruz A; Silva F; Almeida R; David L; Mandel U; Clausen H; Von Mensdorff-Pouilly S; Reis CA
J Histochem Cytochem; 2003 Jun; 51(6):761-71. PubMed ID: 12754287
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells.
Brockhausen I; Yang JM; Burchell J; Whitehouse C; Taylor-Papadimitriou J
Eur J Biochem; 1995 Oct; 233(2):607-17. PubMed ID: 7588808
[TBL] [Abstract][Full Text] [Related]
16. Processing O-glycan core 1, Gal beta 1-3GalNAc alpha-R. Specificities of core 2, UDP-GlcNAc: Gal beta 1-3 GalNAc-R(GlcNAc to GalNAc) beta 6-N-acetylglucosaminyltransferase and CMP-sialic acid: Gal beta 1-3GalNAc-R alpha 3-sialyltransferase.
Kuhns W; Rutz V; Paulsen H; Matta KL; Baker MA; Barner M; Granovsky M; Brockhausen I
Glycoconj J; 1993 Oct; 10(5):381-94. PubMed ID: 8298305
[TBL] [Abstract][Full Text] [Related]
17. Simple mucin-type cancer associated antigens are pre-cancerous biomarkers during 1,2-dimethylhydrazine-induced rat colon carcinogenesis.
Berriel E; Hill M; Barcia JJ; Ubillos L; Gonzalez M; Detjen G; Rondan M; Navarrete H; Osinaga E
Oncol Rep; 2005 Jul; 14(1):219-27. PubMed ID: 15944793
[TBL] [Abstract][Full Text] [Related]
18. UDP-GlcNAc: Gal beta 3GalNAc-mucin: (GlcNAc----GalNAc) beta 6-N-acetylglucosaminyltransferase and UDP-GlcNAc: Gal beta 3(GlcNAc beta 6) GalNAc-mucin (GlcNAc----Gal)beta 3-N-acetylglucosaminyltransferase from swine trachea epithelium.
Sangadala S; Sivakami S; Mendicino J
Mol Cell Biochem; 1991 Mar; 101(2):125-43. PubMed ID: 1830637
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis of incomplete O-glycan synthesis in MCF-7 breast cancer cells: putative role of MUC6 in Tn antigen expression.
Freire T; Bay S; von Mensdorff-Pouilly S; Osinaga E
Cancer Res; 2005 Sep; 65(17):7880-7. PubMed ID: 16140958
[TBL] [Abstract][Full Text] [Related]
20. Kinetic modeling confirms the biosynthesis of mucin core 1 (beta-Gal(1-3) alpha-GalNAc-O-Ser/Thr) O-glycan structures are modulated by neighboring glycosylation effects.
Gerken TA
Biochemistry; 2004 Apr; 43(14):4137-42. PubMed ID: 15065856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
